ArticleMolecular therapy. Nucleic acids2020

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing.

Yu-Chan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.